Trial Profile
Irinotecan toxicity and bilirubin levels in patients with gastrointestinal cancers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer; Gastric cancer; Gastrointestinal cancer
- Focus Adverse reactions; Pharmacodynamics
- 18 Dec 2015 New trial record